Hepatitis C Serology
Alias: HCV, anti-HCV, Hep C
Discipline: Virology
Test information: Used in the diagnosis of acute Hepatitis C infection and determining carrier/donor status. Presence provides evidence of exposure HCV, but does not provide evidence of current active infection. Antibodies usually takes from 6 weeks to 3 months but may take up to six months to develop from time of exposure. In almost all patient's antibody is present by 1 month after onset of acute illness. Therefore, patients with acute hepatitis who initially test negative may need follow-up testing. This test should be used in conjunction with patient history and other hepatitis markers. Newly reactive samples are tested locally for Hepatitis C RNA and if applicable sent to the reference laboratory for genotyping.
Availability: Available locally Monday - Friday during routine hours: 08:45 - 17:15.
Turnaround Time: 3 Days
- Specimen Type(s)
-
- Clotted blood;
- Other Acceptable Specimen Type(s)
- N/A
- Specimen Container - Adult
-
- Gold Top SST BD;
- Specimen Container - Paediatric
-
- Plain Top Sarstedt;
- Analytes
-
- Hepatitis C Virus antibodies;
- Part of a test profile?
- No
- Volume (min) of sample to be sent to laboratory
- 5 - 10mL
- Patient Preparation, Sample Handling and Transport
-
- Minimum-clotting time 30 minutes.
- Specimens should be transported to the laboratory as soon as possible.
- Outside of normal hours samples should be refrigerated (2 °C to 8 °C).
- Do not send grossly haemolysed specimens.
- Maximum add on time
- N/A
- Units and Reference Ranges / Interpretation
-
Hepatitis C Antibody Results: Non-reactive / Reactive
Hepatitis C Antibody Results: Negative / Positive - UKAS number
- 8869
- UKAS accredited test?
- Yes
- Comments
-
- Performance has not been established using cadaver specimens.
- Interference may be encountered with certain sera containing antibodies against reagent components.
- Anti-HCV antibodies may be undetectable in some stages of the infection (acute phase of hepatitis or presence of a serological scar) and in some clinical conditions (immunosuppression).
- Specimens from heparinised patients may be partially coagulated and erroneous results could occur due to the presence of fibrin.
If you have any queries about a test or results interpretation please contact us.
Last updated: 30-05-2023